On June 15, 2018, MIT’s Koch Institute for Integrative Cancer Research will present its 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies. Nanomedicine is a converging field of study in biology and engineering where scientists work at the molecular level to engineer innovative approaches to better detect, monitor, and treat cancer. Experts will discuss how nanotechnology can provide rapid and sensitive detection of cancer, as well as generate entirely novel and highly effective therapeutic agents. The symposium will also feature an industry panel to discuss the impact of nanomedicine on the future of cancer care.
Agenda
Session I: Imaging & Diagnostics
Bubble Based Nanodiagnostics
Sanjiv Sam Gambhir, MD, PhD
Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research
Professor of Bioengineering, Professor of Materials Science and Engineering, Stanford University
Developing Next Generation Diagnostics for Cancer
Ralph Weissleder, MD, PhD
Thrall Professor of Radiology and Professor of Systems Biology, Harvard Medical School
Director of the Center for Systems Biology at Massachusetts General Hospital
New Approaches for Finding Tiny Tumors: Towards Early Detection and Treatment of Ovarian Cancer
Angela Belcher, PhD
James Mason Crafts Professor and Professor of Biological Engineering, MIT
Member, Koch Institute, MIT
Video not available
Session II: Therapeutics
Designing Nanoparticles to Safely Cross the Blood-Brain Barrier for Treating Brain Cancers
Mark E. Davis, PhD
Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology
Member of the City of Hope Comprehensive Cancer Center
Member of the UCLA Jonsson Comprehensive Cancer Center
Video not available
Modulating Tumor-Associated Macrophage
Suzie H. Pun, PhD
Robert F. Rushmer Professor of Bioengineering, Adjunct Professor of Chemical Engineering, University of Washington
Nanoparticle Formulations for RNA Therapy and Gene Editing
Daniel Anderson, PhD
Samuel A. Goldblith Professor of Applied Biology, MIT
Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science, MIT
Member, Koch Institute, MIT
Video not available
Panel: Translation of Nanomedicine to Patients
Moderator: Rebecca Spalding
Biotech Reporter, Bloomberg
Noubar Afeyan, PhD
Founder and CEO, Flagship Pioneering
Michelle S. Bradbury, MD, PhD
Co-Director, MSK-Cornell Center for Translation of Cancer Nanomedicines & Director, Intraoperative Imaging Program
Member, Molecular Pharmacology Program, Sloan Kettering Institute
Attending, Radiology, Memorial Sloan Kettering Cancer Center
Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences & Weill Medical College of Cornell University
Paula Hammond, PhD
Head, Department of Chemical Engineering, MIT
David H. Koch Professor of Engineering, MIT
Member, Koch Institute, MIT
Robert Langer, ScD
David H. Koch Institute Professor
Member, Koch Institute, MIT
John Maraganore, PhD
CEO and Director, Alnylam
Cristianne Rijcken, PhD
Founder and Chief Scientific Officer, Cristal Therapeutics
Session III: Nanosystems and Devices
Protease Nanosensors for Cancer Detection, Classification and Monitoring
Sangeeta Bhatia, MD, PhD
Director, Marble Center for Cancer Nanomedicine
John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science, MIT
Member, Koch Institute, MIT
Investigator, Howard Hughes Medical Institute
Micro and Nanotechnologies for Analysis of Tissues and Molecules
Rashid Bashir, PhD
Executive Associate Dean and Chief Diversity Officer, Carle Illinois College of Medicine
Grainger Distinguished Chair in Engineering, Professor of Bioengineering, Electrical and Computer Engineering, Mechanical Science and Engineering, Materials Science and Engineering, and Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign
A Molecular View of Immuno-Oncology
James R. Heath, PhD
President and Professor, Institute for Systems Biology
Professor of Molecular and Medical Pharmacology, UCLA
Special Presentation: Overview of MIT.nano
Nanoscale Discoveries for Transformative Breakthroughs
Vladimir Bulović, PhD
Director, MIT.nano
Associate Dean for Innovation, MIT School of Engineering
Fariborz Maseeh (1990) Professor of Emerging Technology, Department of Electrical Engineering and Computer Science (EECS), MIT